Ardent Health, Inc.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.62B | $1.60B | $1.61B | $1.58B | $1.65B | $1.50B | $1.61B | $1.45B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $61.2M | $48.6M | $36.8M | $36.5M | $32.6M | $34.9M | $36.7M | $33.7M |
| Operating Income | $43.2M | $74.6M | $92.4M | $-2.2M | $122.0M | $74.2M | $167.2M | $57.1M |
| Operating Margin | 2.7% | 4.7% | 5.8% | -0.1% | 7.4% | 5.0% | 10.4% | 3.9% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $43.2M | $74.6M | $92.4M | $-2.2M | $122.0M | $74.2M | $167.2M | $57.1M |
| Income Tax Expense | $8.5M | $16.1M | $18.1M | $-3.4M | $26.3M | $15.2M | $26.4M | $11.1M |
| Net Income | $16.9M | $39.9M | $45.0M | $-23.5M | $73.0M | $41.4M | $114.2M | $26.3M |
| Net Margin | 1.0% | 2.5% | 2.8% | -1.5% | 4.4% | 2.8% | 7.1% | 1.8% |
| EPS (Basic) | $0.12 | $0.28 | $0.31 | $-0.17 | $0.52 | $0.30 | $0.85 | $0.19 |
| EPS (Diluted) | $0.12 | $0.28 | $0.32 | $-0.17 | $0.52 | $0.29 | $0.84 | $0.19 |
| Shares Outstanding (Basic) | 141.7M | 141.3M | 140.8M | 141.2M | 140.4M | 140.1M | 132.4M | 137.1M |
| Shares Outstanding (Diluted) | 143.1M | 141.8M | 141.5M | 141.2M | 141.5M | 140.7M | 132.7M | 137.5M |
| Dividends Per Share | — | — | — | — | — | — | — | — |